Clinical Effectiveness of Botulinum Toxin Type B in the Treatment of Subacromial Bursitis or Shoulder Impingement Syndrome

Lee, Jung Hwan; Lee, Sang-Ho; Song, Sun Hong

doi:10.1097/ajp.0b013e31820e1310

Cited by 17 publications

(23 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This recommendation was based on findings that radiologic analyses were frequently incompatible with the clinical manifestation. 67 The literature often reports that X-ray and US imaging are used to confirm a diagnosis of SIS; however, it would be more accurate to state that their primary use is to confirm the exclusion of other pathologies. Neer's original work in 1972 reported using arthrograms to determine rotator cuff integrity, on the grounds that abnormalities such as chronic bursitis, partial-thickness tears, calcium deposits and complete tears could not be distinguished by physical examinations and radiographic findings alone.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, half used two or more radiological investigations in their diagnostic methodology. Lee et al 67 discussed that US and MRI often fail to provide useful information for assessing the patients and that these investigations should not be used as diagnostic instruments to identify shoulder lesions. This recommendation was based on findings that radiologic analyses were frequently incompatible with the clinical manifestation.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Shoulder impingement syndrome: a systematic review of clinical trial participant selection criteria

et al. 2016

View full text Add to dashboard Cite

Background: Shoulder impingement syndrome (SIS) is a common diagnosis for patients with pain and dysfunction of the shoulder. Variations in the signs and symptoms might lead to uncertainty regarding the definition of SIS. The aim of this review is to explore the participant selection criteria used in the literature when investigating SIS and to assess differences in criteria among treating professions. Methods: This is a PRISMA systematic review of publications from 2009 to 2014 from MEDLINE, PubMed, The Cochrane Library, Embase, Scopus and CINAHL. Results: Ninety-seven articles met inclusion criteria for this review. Twenty-five different surgical and nonsurgical treatments were investigated. Impingement-specific index tests were used in all studies. Exclusion index tests were used in 62% of studies. Twenty index tests were identified. Radiological investigations were reported in 53% of all studies, of which a further 53% reported using two or more radiological investigations. Conclusions: This systematic review has illustrated that studies investigating SIS test for various signs and symptoms, which is in keeping with describing the condition as a 'syndrome'. However, there are inconsistencies in participant selection criteria between health disciplines, highlighting a need for harmonization of the selection criteria in the form of an international editorial consensus.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Shoulder impingement syndrome: a systematic review of clinical trial participant selection criteria

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Ten were further excluded because four lacked a control group [10,[13][14][15], five targeted myofascial pain in regions other than shoulder areas [16][17][18][19][20], and one used an enriched protocol design to assess the effect of repeated BoNT injections [14] (Figure 1). The final meta-analysis consisted of seven 2-armed [21][22][23][24][25][26][27], one 3-armed [28], and one 4-armed [29] trials. Of the four studies investigating shoulder joint pain, one targeted patients with refractory shoulder pain [27], one targeted those with subacromial bursitis or shoulder impingement syndrome [25], one targeted those with adhesive capsulitis [24], and one was shoulder osteoarthritis [23].…”

Section: Study Identification and Selectionmentioning

confidence: 99%

Comparative Effectiveness of Botulinum Toxin Injection for Chronic Shoulder Pain: A Meta-Analysis of Randomized Controlled Trials

Hsu

Han

et al. 2020

Toxins

View full text Add to dashboard Cite

Botulinum toxin (BoNT) injection is regarded as a promising treatment for musculoskeletal pain. However, its efficacy for treating chronic shoulder pain remains unclear. We investigated the effectiveness of BoNT injections for chronic shoulder pain by conducting a systematic search of electronic databases up to March 2020 for randomized control trials (RCTs) that used BoNT injections for chronic shoulder pain treatment. The primary outcome was the between-group comparison of pain reduction, quantified by the standardized mean difference (SMD). Nine RCTs comprising 666 patients were included and divided into two groups: one group with shoulder joint pain (n = 182) and the other group with shoulder myofascial pain (n = 484). Regarding shoulder joint pain, the efficacy of BoNT injections was similar to that of the reference treatment (SMD: −0.605, 95% confidence level [CI]: −1.242 to 0.032 versus saline; SMD: −0.180, 95% CI: −0.514 to 0.153 versus corticosteroids) at one month post-intervention, and was superior (SMD: −0.648, 95% CI: −0.1071 to −0.225 versus corticosteroids) between one and three months. Likewise, in terms of shoulder myofascial pain, the effectiveness of BoNT injections did not differ from the reference treatment (SMD: −0.212, 95% CI: −0.551 to 0.127 versus saline; SMD: 0.665, 95% CI: −0.260 to 1.590 versus dry needling and SMD: 1.093; 95% CI: 0.128 to 2.058 versus lidocaine) at one month post- intervention, and appeared superior (SMD: −0.314, 95% CI: −0.516 to −0.111 versus saline) between one and three months. Our meta-analysis revealed that BoNT injections could be a safe and effective alternative for patients with chronic shoulder pain.

show abstract

“…The 117 shoulder pain was due to hemiplegia in six studies 8,9,12,13,14,15 . The other causes of shoulder pain were 118 adhesive capsulitis 17 , sub-acromial bursitis (SB) or shoulder impingement syndrome (SIS) 18 , and shoulder 119 arthritis pain 16 . The primary finding of this meta-analysis is that BTX treatments resulted in small to 120 moderate pain relief and shoulder abduction ROM increase in patients with chronic shoulder pain due to 121 spastic hemiplegia or arthritis or sub-acromial bursitis or adhesive capsulitis.…”

mentioning

confidence: 99%

“…The route of administration differed in the three conditions, intramuscular for hemiplegia 8,9,12,13,14,15 , 135 intra-articular for arthritis 16 or adhesive capsulitis 17 , and intra sub-acromial bursitis for shoulder 136 impingement syndrome 18 .…”

mentioning

confidence: 99%

Effectiveness of Botulinum Toxin for Shoulder Pain Treatment: A Systematic Review and Meta-Analysis

Fu²,

Song

et al. 2015

Archives of Physical Medicine and Rehabilitation

View full text Add to dashboard Cite

Clinical Effectiveness of Botulinum Toxin Type B in the Treatment of Subacromial Bursitis or Shoulder Impingement Syndrome

Abstract: BT type B can be a useful strategy and has great potential for replacing steroids as a treatment for SB or SIS.

Cited by 17 publications

References 48 publications

Shoulder impingement syndrome: a systematic review of clinical trial participant selection criteria

Shoulder impingement syndrome: a systematic review of clinical trial participant selection criteria

Comparative Effectiveness of Botulinum Toxin Injection for Chronic Shoulder Pain: A Meta-Analysis of Randomized Controlled Trials

Effectiveness of Botulinum Toxin for Shoulder Pain Treatment: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About